Your session is about to expire
← Back to Search
Dextrose Injection for PTSD
Study Summary
This trial will compare the effects of dextrose injection on reducing anxiety, brain fog, and depression in patients with PTSD.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have tried at least 2 non-drug treatments for PTSD.I can provide 2 emails and 2 phone numbers for contact.My chronic pain is mild, at or below 5 out of 10.You have a score of 26 or higher on the CAPS-5 Rating scale.I have tried at least 2 medications for PTSD.I do not take daily painkillers.My chronic pain is mild, at or below 5 out of 10.I have had symptoms for over a year.I am willing to answer questions multiple times over a year.I am willing to follow the usual care treatment for 3 months.I do not have any major surgeries planned.You do not currently have any plans to harm yourself.I have had symptoms for over a year.I have tried at least 2 non-drug treatments for PTSD.You should not regularly consume more than 3 alcoholic drinks in a day.I do not have any terminal illnesses.I have tried at least 2 medications for PTSD without success.You are not extremely afraid of needles.
- Group 1: Waiting period with usual care
- Group 2: BCPHD-D5W with usual care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any open enrollments for this medical research project?
"Unfortunately, this study is not currently enrolling patients. It was published on November 1st 2021 and last altered on August 30th 2021. Nevertheless, there are 317 distinct trials that have openings for participants at present."
Am I eligible to join this research study?
"Candidates for this trial should have a diagnosis of posttraumatic stress disorder (PTSD) and be between the ages 19 to 90. Approximately 120 patients will be included in the study."
What aims are being sought through this scientific experiment?
"The principal aim of this research trial, which is expected to conclude in approximately 3 months' time, will be measured by the Hospital Anxiety and Depression scale. Additionally, a 0-10 Numerical Rating Scale for Anxiety—where "0" denotes no anxiety and "10" implies extreme distress—and EuroQOL-5D-5L + C scale (which measures general quality of life on a range from 1 to 5) as well as Satisfaction with comfort of procedure using another 0-10 numerical rating system shall also be gauged. A reduction in scores across all evaluations would indicate improvement."
Is this research protocol open to participants aged 75 and older?
"This medical experiment is recruiting participants aged 19 and over, up to the age of 90."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger